The authors showed that high feline sarcoma-related non-receptor tyrosine kinase (FER) levels were also associated with improved outcomes after adjuvant taxane-based combination chemotherapy in high-risk, HER2-negative patients.
[Cell Reports]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
173748
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
